Springer Seminars in Immunopathology

, Volume 4, Issue 3, pp 209–219 | Cite as

The role of complement in phototoxic reactions

  • Henry Lim
  • Irma Gigli
Article

Keywords

Internal Medicine Phototoxic Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bodammer G, Vogt W (1970) Beeinflussung der Capillarpermeabilität in der Meerschweinchenhaut durch Anaphylatoxin (AT) Naunyn Schmiedebergs Arch Pharmacol 266: 255PubMedGoogle Scholar
  2. 2.
    Bokisch VA, Müller-Eberhard HJ (1970) Anaphylatoxin inactivation of human plasma: Its isolation and characterization as a carboxypeptidase. J Clin Invest 49: 2427PubMedGoogle Scholar
  3. 3.
    Bokisch VA, Müller-Eberhard HJ, Cochrane CG (1969) Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med 129: 1109PubMedGoogle Scholar
  4. 4.
    Bolande RP, Wurz L, Ecker EE (1963) Photodynamic action II. The effects of photodynamic action on certain properties of human serum. Arch Pathol 75: 123PubMedGoogle Scholar
  5. 5.
    Budzko DB, Bokisch VA, Müller-Eberhard HJ (1971) A fragment of the third component of human complement with anaphylatoxin activity. Biochemistry 10: 1166PubMedGoogle Scholar
  6. 6.
    Cochrane CG, Müller-Eberhard HJ (1968) The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med 127: 371PubMedGoogle Scholar
  7. 7.
    Cochrane CG, Müller-Eberhard HJ, Aikin BS (1970) Depletion of plasma complement in vivo by a protein of cobra venom: Its effect on various immunologic reactions. J Immunol 105: 55PubMedGoogle Scholar
  8. 8.
    Epstein S (1939) Photoallergy and primary photosensitivity to sulfanilamide. J Invest Dermatol 2:43Google Scholar
  9. 9.
    Epstein JH, Tuffanelli DL, Epstein WL (1973) Cutaneous changes in the porphyrias. Arch Dermatol 107: 689PubMedGoogle Scholar
  10. 10.
    Friedberger VE (1910) Weitere Untersuchungen über Eiweißbanaphylaxie. Z Immunitätsforsch 4: 636Google Scholar
  11. 11.
    Gigh I (1981) The complement system: Mechanisms of action, biology and participation in dermatological diseases. In: B Safai, RA Good (eds) Immunodermatology. Plenum Press, New York, p 65Google Scholar
  12. 12.
    Goldstein BD, Harber LC (1972) Erythropoietic protoporphyria: Lipid peroxidation and red cell membrane damage associated with photohemolysis. J Clin Invest 51: 892PubMedGoogle Scholar
  13. 13.
    Gorski JP, Hugh TE, Müller-Eberhard HJ (1979) C4a: The third anaphylatoxin of the human complement system. Proc Natl Acad Sci USA 76: 5299PubMedGoogle Scholar
  14. 14.
    Harber LC, Baer RL (1978) Reactions to light, heat and trauma. In: M Samter (ed) Immunological diseases, 3rd ed. Little, Brown and Co Boston, p 1014Google Scholar
  15. 15.
    Harber LC, Bickers DR (1975) Porphyrias: Basic science aspects, clinical diagnosis and management. In: F P Malkinson, RW Pearson (eds) Yearbook of dermatology. Yearbook Medical Publishers, Chicago, p 9Google Scholar
  16. 16.
    Hugh TE (1975) Serum anaphylatoxins: Formation, characterization and control. In: E Reich, DB Rifkin, E Shaw (eds) Proteases in biological control. Cold Spring Harbor Laboratory, p 273Google Scholar
  17. 17.
    Jensen J (1967) Anaphylatoxin in its relation to the complement system. Science 155: 1122PubMedGoogle Scholar
  18. 18.
    Konrad K, Honigsmann H, Gschnait F, Wolff K (1975) Mouse model for protoporphyria. II. Cellular and subcellular events in the photosensitivity flare of the skin. J Invest Dermatol 65: 300PubMedGoogle Scholar
  19. 19.
    Lepow IH, Da Silva W, Eisele JW (1968) Nature and biological properties of human anaphylatoxin. In: KF Austen, EL Becker (eds) Biochemistry of the acute allergic reaction. Blackwell, Oxford, p 265Google Scholar
  20. 20.
    Lepow IH, Williams-Kretschmer K, Patrick RA, Rosen FS (1970) Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man. Am J Pathol 61: 13PubMedGoogle Scholar
  21. 21.
    Lim HW, Perez HD, Goldstein IM, Gigli I (1981) Complement-derived chemotactic activity is generated inhuman serum containing uroporphyrin after irradiation with 405 nm light. J Clin Invest 67: 1072PubMedGoogle Scholar
  22. 22.
    Lim HW, Perez HD, Poh-Fitzpatrick M, Goldstein IM, Gigli I (1981) Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda. N Engl J Med 304: 212PubMedGoogle Scholar
  23. 23.
    Müller-Eberhard HJ (1972) The molecular basis of the biological activities of complement. In: The Harvey lectures, Series 66. Academic Press, New York, p 75Google Scholar
  24. 24.
    Osler AG, Randall HG, Hill BM, Ovary Z (1959) Some relationships between complement, passive cutaneous anaphylaxis and anaphylatoxin. In: JF Shaffer, GA LoGrippo, MW Chase (eds) Mechanisms of hypersensitivity. Little, Brown and Co, Boston, p 281Google Scholar
  25. 25.
    Parrish JA, White HAD, Pathak MA (1979) Photomedicine. In: TB Fitzpatrick, AZ Eisen, K Wolff, IM Freedberg, KF Austen (eds) Dermatology in general medicine, 2nd ed. McGraw-Hill, New York, p 942Google Scholar
  26. 26.
    Sams WM Jr, Epstein JH (1967) The experimental production of drug phototoxicity in Guinea pigs. l. Using sunlight. J Invest Dermatol 48: 89PubMedGoogle Scholar
  27. 27.
    Schnait FG, Wolff K, Konrad K (1975) Erythropoietic protoporphyria-submicroscopic events during the acute photosensitivity flare. Br J Dermatol 92: 545PubMedGoogle Scholar
  28. 28.
    Torinuki W, Miura T, Seiji M (1980) Lysosome destruction and lipoperoxidase formation due to active oxygen generated from haematoporphyrin and UV irradiation. Br J Dermatol 102: 17PubMedGoogle Scholar
  29. 29.
    Vallota EH, Müller-Eberhard HJ (1973) Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J Exp Med 137: 1109PubMedGoogle Scholar
  30. 30.
    Vogt W, Schmidt G, von Buttlar B, Dieminger L (1978) A new function of the activated third component of complement: Binding to C5, an essential step for C5 activation. Immunology 34: 29PubMedGoogle Scholar
  31. 31.
    Vogt W, Zeman N, Garbe G (1969) Histaminunabhängige wirkungen von anaphylatoxin auf glatte muskulature isolierter organe. Naunyn Schmiedebergs Arch Pharmacol Exp Pathol 262: 399Google Scholar
  32. 32.
    Ward PA (1979) The heterogeneity of chemotactic factors for neutrophils generated from the complement system. In: HZ Movat (ed) Cellular and humoral mechanism in anaphylaxis and allergy. Karger, Basel, p 279Google Scholar
  33. 33.
    Wuepper KD, Bokisch VA, Müller-Eberhard HJ, Stoughton RB (1972) Cutaneous responses to human C3 anaphylatoxin in man. Clin Exp Immunol 11: 13PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • Henry Lim
    • 1
  • Irma Gigli
    • 1
  1. 1.Departments of Dermatology and Medicine, Irvington House InstituteNew York University Medical CenterNew YorkUSA

Personalised recommendations